Hosted on MSN20d
Johnson & Johnson and 4 Other Biopharmaceutical Stocks That Might Be Ready to Break OutBofA Securities analyst Tim Anderson sees promise for a handful of large-cap competitors. In a note Wednesday, he said the biopharma sector has become more defensive over the past few weeks ...
TEMPE, Ariz. — A good redemption story is enticing. With Tim Anderson, it is also complicated. The veteran is in Angels camp this spring, forced to prove himself on a minor-league contract.
Hosted on MSN28d
Tim Anderson Could Open The Year At ShortstopLos Angeles Angels shortstop Tim Anderson could have a shot to be the team's Opening Day shortstop in 2025 with Zach Neto (shoulder) expected to open the season on the injured list after having ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results